<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01873820</url>
  </required_header>
  <id_info>
    <org_study_id>07EAHT</org_study_id>
    <nct_id>NCT01873820</nct_id>
  </id_info>
  <brief_title>Tolerance of Two Forms of Vitamin C in Acid-sensitive Adults</brief_title>
  <official_title>A Randomized, Double-blind, Crossover Study Comparing the Tolerance of Two Forms of Vitamin C in Acid Sensitive Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NBTY, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KGK Synergize Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Moyad, Mark MD MPH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NBTY, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the tolerance of two forms of vitamin C in adults
      with sensitivity to acidic foods.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Gastrointestinal Symptom Rating Scale at 5 and 10 days</measure>
    <time_frame>0, 5 and 10 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Tolerance</condition>
  <arm_group>
    <arm_group_label>Calcium ascorbate -&gt; ascorbic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ascorbic acid -&gt; calcium ascorbate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium ascorbate</intervention_name>
    <arm_group_label>Calcium ascorbate -&gt; ascorbic acid</arm_group_label>
    <arm_group_label>Ascorbic acid -&gt; calcium ascorbate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ascorbic acid</intervention_name>
    <arm_group_label>Calcium ascorbate -&gt; ascorbic acid</arm_group_label>
    <arm_group_label>Ascorbic acid -&gt; calcium ascorbate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy as determined by laboratory results and medical history

          -  Females not of child bearing potential

          -  Self-reported sensitivity to acidic foods

          -  Agrees to consume a low vitamin C diet

        Exclusion Criteria:

          -  Pregnant, breastfeeding, or planning to become pregnant during the trial

          -  Use of medications known to interact with vitamin C or cause epigastric effects

          -  Use of supplements containing containing vitamin C

          -  Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux
             disease (GERD) within past 3 months

          -  Use of antacids and/or acid suppressors within 4 weeks of randomization

          -  History of irritable bowel syndrome and related disorders

          -  Alcohol use &gt; 2 standard alcoholic drinks per day; alcohol or drug abuse within the
             past year

          -  History of cardiac disease within the past 6 months

          -  History of or current diagnosis of cancer

          -  Uncontrolled hypertension

          -  Unstable renal and/or liver disease

          -  History of kidney stones

          -  Unstable psychiatric disorder

          -  History of or current immunocompromise

          -  History of hemoglobinopathies

          -  Participation in another clinical research trial &lt;30 days

          -  Abnormal liver function

          -  Serum creatinine &gt; 1.5 x upper limit of normal (ULN)

          -  Anemia of any etiology

          -  Uncontrolled and/or untreated thyroid disorder

          -  BMI â‰¥ 35 kg/m2

          -  Unstable medications &lt;30 days

          -  Allergy or sensitivity to test article ingredients

          -  Cognitively impaired and/or unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>David Crowley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KGK Synergize Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KGK Synergize, Inc</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2013</study_first_posted>
  <last_update_submitted>June 6, 2013</last_update_submitted>
  <last_update_submitted_qc>June 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin C</keyword>
  <keyword>calcium ascorbate</keyword>
  <keyword>ascorbic acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Calcium ascorbate</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

